Vivid iq
GE Medical Systems Ultrasound & Primary Care Diagnostics LLC • Radiology • 07/18/2022
Device Purpose
The Vivid iq is a compact, high-performance diagnostic ultrasound system designed for cardiovascular and shared service applications, employing various electronic array transducers and imaging modes including Doppler and real-time 3D. It incorporates advanced software, including AI-powered tools like Easy Auto EF and Easy AFI LV for enhanced cardiac assessment, workflow optimization features, and expanded clinical capabilities such as Thoracic/Pleural imaging, all based on established ultrasound principles.
Summary
The Vivid iq system is a general-purpose, compact diagnostic ultrasound device designed primarily for cardiovascular diagnostic use and shared service imaging. It features a console with a control panel, a color LCD Touch Panel, optional cart with an extended battery, and capabilities for image storage and wireless connectivity. The system utilizes a variety of electronic array transducers, including linear, curved, sector/phased array, matrix array, dual array, dedicated CW, real-time 3D, and compatible ICE transducers, to perform ultrasound imaging, measurement, display, and analysis. Its extensive clinical applications cover Fetal/Obstetrics, Abdominal, Pediatric, Small Organs, Cardiac, Vascular, Musculoskeletal, Urology, and various transeptal/interventional procedures, supported by multiple operating modes such as B-mode, M-mode, PW/CW Doppler, Color Doppler, and Harmonic Imaging. The Vivid iq leverages the same fundamental scientific technology as its predicate devices while introducing significant updates. These include an expanded Thoracic/Pleural clinical application, new transducer compatibilities (10T-D, L4-20t-RS), and numerous software enhancements. Notable software additions are workflow tools like Dual Crop and Image Spooler, AI-powered features such as Easy Auto EF and Easy AFI LV (which demonstrated high accuracy with dice scores ≥91-92% in testing on diverse datasets), Strain Elastography, a Spline Tool for measurements, and Probe check functionality. The system has undergone non-clinical testing for acoustic output, biocompatibility, safety, and compliance with standards including AAMI/ANSI ES60601-1, IEC 60601-1-2, and IEC 60601-2-37, ensuring its reliability for clinical use.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the performance of the AI-driven 'Easy Auto EF' and 'Easy AFI LV' features, particularly the AI Auto ROI algorithm, compare to manual measurements by experienced sonographers across diverse patient populations with varying cardiac pathologies?; What specific improvements do the workflow enhancement tools (Dual Crop, Pre-Post Compare, Image Spooler) offer in terms of reducing examination time and improving diagnostic efficiency in high-volume clinical settings?; Could the 'Imaging Insights Data Collection Support' feature be utilized for large-scale research to identify trends in device usage, common pathologies, or areas for future ultrasound technology development?; With the addition of the Thoracic/Pleural application and new transducers like L4-20t-RS, what is the quantified impact on diagnostic capabilities for lung and pleural pathologies compared to previous versions or dedicated thoracic ultrasound systems?; What is the learning curve associated with the new software features, including the AI tools like Easy Auto EF, Easy AFI LV, and Strain Elastography, for sonographers with varying levels of experience with GE Vivid systems?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly